Viracta Therapeutics, Inc. (VIRX) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts VIRX Hot Sheet
Join SI Premium – FREE
Viracta Therapeutics, Inc. (NASDAQ: VIRX) reported Q3 EPS of ($0.33), $0.02 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Viracta Therapeutics, Inc. (VIRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- AeroVironment restates quarterly financials, citing $89M goodwill error
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
